OJPed  Vol.3 No.4 , December 2013
Comparison of treatment guidance based on bronchial responsiveness to mannitol, spirometry or exhaled nitric oxide in stable asthmatic children

Aim: The goal of this study was to compare asthma treatment guidance based on bronchial hyper-responsiveness to mannitol, spirometry or exhaled nitric oxide (FeNO) in stable asthmatic children. Methods: 60 stable allergic asthmatic children aged 7 to 16 years on a low to medium dose treatment with inhaled corticosteroids (ICS) were recruited to a double blind randomised controlled trial. At study entry (visit 1), the following was assessed: FeNO, spirometry, bronchial hyper-responsiveness to mannitol (MDP- test), quality of life (paediatric asthma quality-of-life questionnaire; PAQLQ) and asthma control (asthma control test; ACT). Subjects were randomly assigned to one of three groups and treatment was modified by a blinded respiratory physician according to the test results of visit 1: ICS dose was doubled when FeNO was >22 ppb (group 1), in case of a positive MDP-test (group 2) or when FEV1 was <80% of a predicted one (group 3), respectively, or remained unchanged for the remaining subjects. After 3 months (visit 2), the subjects were reassessed and all tests were repeated. Results: 48 children successfully completed the study. At the first visit, 8 out of 16 (50%) children in group 1 showed a FeNO > 22 ppb, 8 children out of 16 (50%) in group 2 showed a positive MDP-test and 3 children out of 16 (18.7%) in group 3 had a FEV1 < 80% of that predicted and had their ICS-dose doubled. In group 1, FeNO decreased significantly after the intervention (p = 0.005), whereas the self-administered and the interviewer-administered PAQLQ (p = 0.02 resp. p = 0.033) as well as the ACT (p = 0.031) increased. Neither the number of children with a positive mannitol challenge nor spirometric results changed significantly. In group 2 and group 3, there were no significant changes in none of the assessed parameters. Conclusion: In this small pragmatic double blind randomised controlled study, we showed that ICS dose modification based on FeNO led to increased quality of life and enhanced asthma control, and to a reduction in airway inflammation and was superior to treatment modifications based on bronchial hyper-responsiveness to mannitol or on FEV1.

Cite this paper
Patrick, L. , Demet, I. , Andreas, J. , Bruno, K. , Heinrich, W. and Alexander, M. (2013) Comparison of treatment guidance based on bronchial responsiveness to mannitol, spirometry or exhaled nitric oxide in stable asthmatic children. Open Journal of Pediatrics, 3, 406-417. doi: 10.4236/ojped.2013.34074.
[1]   Global Initiative for Asthma (GINA) (2012) Global strategy for asthma management and prevention. http://www.ginasthma.org/

[2]   Rabe, K.F., Adachi, M., Lai, C.K.W., Soriano, J.B., Vermeire, P.A., Weiss, K.B., et al. (2004) Worldwide severity and control of asthma in children and adults: The global asthma insights and reality surveys. Journal of Allergy and Clinical Immunology, 114, 40-47. http://dx.doi.org/10.1016/j.jaci.2004.04.042

[3]   Gustafsson, P.M., Watson, L., Davis, K.J. and Rabe, K.F. (2006) Poor asthma control in children: Evidence from epidemiological surveys and implications for clinical practice. International Journal of Clinical Practice, 60, 321334. http://dx.doi.org/10.1111/j.1368-5031.2006.00798.x

[4]   Sont, J.K., Willems, L.N., Bel, E.H., van Krieken, J.H., Vandenbroucke, J.P., and Sterk, P.J. (1999) Clinical control and histopathologic outcome of asthma when using airway hyper-responsiveness as an additional guide to long-term treatment. The AMPUL Study Group. American Journal of Respiratory and Critical Care Medicine, 159, 1043-1051. http://dx.doi.org/10.1164/ajrccm.159.4.9806052

[5]   Moeller, A., Steurer-Stey, C., Suter, H., Hofer, M., Peter, M., Brooks-Wildhaber, J., et al. (2006) Disease control in asthmatic children seen in private practice in Switzerland. Current Medical Research and Opinion, 22, 1295-1306. http://dx.doi.org/10.1185/030079906X112633

[6]   Juniper, E.F., Gruffydd-Jones, K., Ward, S. and Svensson, K. (2010) Asthma control questionnaire in children: Validation, measurement properties, interpretation. European Respiratory Journal, 36, 1410-1416. http://dx.doi.org/10.1183/09031936.00117509

[7]   LeBlanc, A., Robichaud, P., Lacasse, Y. and Boulet, L.P. (2007) Quantification of asthma control: Validation of the asthma control scoring system. Allergy, 62, 120-125. http://dx.doi.org/10.1111/ j.1398-9995.2006.01194.x

[8]   Nathan, R.A., Sorkness, C.A., Kosinski, M., Schatz, M., Li, J.T., Marcus, P., et al. (2004) Development of the asthma control test: A survey for assessing asthma control. Journal of Allergy and Clinical Immunology, 113, 59-65. http://dx.doi.org/10.1016/j.jaci.2003.09.008

[9]   Papakosta, D., Latsios, D., Manika, K., Porpodis, K., Kontakioti, E. and Gioulekas, D. (2011) Asthma control test is correlated to FEV1 and nitric oxide in Greek asthmatic patients: Influence of treatment. Journal of Asthma, 48, 901-906. http://dx.doi.org/10.3109/02770903.2011.611958

[10]   Kuehni, C.E. and Frey, U. (2002) Age-related differences in perceived asthma control in childhood: Guidelines and reality. European Respiratory Journal, 20, 880-889. http://dx.doi.org/10.1183/ 09031936.02.00258502

[11]   Nuijsink, M., Hop, W.C.J., Sterk, P.J., Duiverman, E.J., de Jongste, J.C. and on Behalf of the Children Asthma Therapy Optimal (CATO) Study Group (2007) Long-term asthma treatment guided by airway hyperresponsiveness in children: A randomised controlled trial. European Respiratory Journal, 30, 457-466. http://dx.doi.org/10.1183/09031936.00111806

[12]   Wildhaber, J.H., Sznitman, J., Harpes, P., Straub, D., M?ller, A., Basek, P., et al. (2007) Correlation of spirometry and symptom scores in childhood asthma and the usefulness of curvature assessment in expiratory flowvolume curves. Respiratory Care, 52, 1744-1752.

[13]   Bacharier, L.B., Strunk, R.C., Mauger, D., White, D., Lemanske Jr, R.F. and Sorkness, C.A. (2004) Classifying asthma severity in children: Mismatch between symptoms, medication use, and lung function. American Journal of Respiratory and Critical Care Medicine, 170, 426432.

[14]   Mehta, V., Stokes, J.R., Berro, A., Romero, F.A. and Casale, T.B. (2009) Time-dependent effects of inhaled corticosteroids on lung function, bronchial hyperresponsiveness, and airway inflammation in asthma. Annals of Allergy, Asthma and Immunology, 103, 31-37. http://dx.doi.org/10.1016/S1081-1206(10)60140-8

[15]   Van Grunsven, P.M., van Schayck, C.P., Molema, J., Akkermans, R.P. and van Weel, C. (1999) Effect of inhaled corticosteroids on bronchial responsiveness in patients with “corticosteroid naive” mild asthma: A metaanalysis. Thorax, 54, 316-322. http://dx.doi.org/10.1136/thx.54.4.316

[16]   Griese, M., Koch, M., Latzin, P. and Beck, J. (2000) Asthma severity, recommended changes of inhaled therapy and exhaled nitric oxide in children: A prospective, blinded trial. European Journal of Medical Research, 18, 334-340.

[17]   Pijnenburg, M.W., Bakker, E.M., Hop, W.C. and de Jongste, J.C. (2005) Titrating steroids on exhaled nitric oxide in children with asthma: A randomized controlled trial. American Journal of Respiratory and Critical Care Medicine, 172, 831-836. http://dx.doi.org/10.1164/rccm.200503-458OC

[18]   Pijnenburg, M.W., Hofhuis, W., Hop, W.C. and de Jongste, J.C. (2005) Exhaled nitric oxide predicts asthma relapse in children with clinical asthma remission. Thorax, 60, 215-218.

[19]   Zacharasiewicz, A., Wilson, N., Lex, C., Erin, E.M., Li, A.M., Hansel, T., et al. (2005) Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children. American Journal of Respiratory and Critical Care Medicine, 171, 1077-1082. http://dx.doi.org/10.1164/rccm.200409-1242OC

[20]   Jatakanon, A., Kharitonov, S., Lim, S. and Barnes, P.J. (1999) Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma. Thorax, 54, 108-114. http://dx.doi.org/10.1136/thx.54.2.108

[21]   Kharitonov, S.A., Yates, D.H., and Barnes, P.J. (1996) Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. American Journal of Respiratory and Critical Care Medicine, 153, 454-457. http://dx.doi.org/10.1164/ajrccm.153.1.8542158

[22]   Little, S.A., Chalmers, G.W., MacLeod, K.J., McSharry, C. and Thomson, N.C. (2000) Non-invasive markers of airway inflammation as predictors of oral steroid responsiveness in asthma. Thorax, 55, 232-234. http://dx.doi.org/10.1136/thorax.55.3.232

[23]   Smith, A.D., Cowan, J.O., Filsell, S., McLachlan, C., Monti-Sheehan, G., Jackson, P., et al. (2004) Diagnosing asthma: Comparisons between exhaled nitric oxide measurements and conventional tests. American Journal of Respiratory and Critical Care Medicine, 169, 473-478.

[24]   Kharitonov, S.A., Gonio, F., Kelly, C., Meah, S. and Barnes, P.J. (2003) Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children. European Respiratory Journal, 21, 433-438. http://dx.doi.org/10.1183/09031936.03.00066903a

[25]   Deykin, A., Massaro, A.F., Drazen, J.M. and Israel, E. (2002) Exhaled nitric oxide as a diagnostic test for asthma: Online versus offline techniques and effect of flow rate. American Journal of Respiratory and Critical Care Medicine, 165, 1597-1601. http://dx.doi.org/10.1164/rccm.2201081

[26]   Michils, A., Baldassarre, S. and Van Muylem, A. (2008) Exhaled nitric oxide and asthma control: A longitudinal study in unselected patients. European Respiratory Journal, 31, 539-546. http://dx.doi.org/10.1183/09031936.00020407

[27]   Senna, G., Passalacqua, G., Schiappoli, M., Lombardi, C. and Wilcock, L. (2007) Correlation among FEV1, nitric oxide and asthma control test in newly diagnosed asthma. Allergy, 62, 207-212. http://dx.doi.org/10.1111/j.1398-9995.2006.01250.x

[28]   Kharitonov, S.A., Donnelly, L.E., Montuschi, P., Corradi, M., Collins, J.V. and Barnes, P.J. (2002) Dose-dependent onset and cessation of action of inhaled budesonide on exhaled nitric oxide and symptoms in mild asthma. Thorax, 57, 889-896. http://dx.doi.org/10.1136/thorax.57.10.889

[29]   Shaw, D.E., Berry, M.A., Thomas, M., Green, R.H., Brightling, C.E., Wardlaw, A.J., et al. (2007) The use of exhaled nitric oxide to guide asthma management: A randomized controlled trial. European Respiratory Journal, 176, 231-237.

[30]   Smith, A.D., Cowan, J.O., Brassett, K.P., Herbison, G.P. and Taylor, D.R. (2005) Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. New England Journal of Medicine, 352, 2163-2173. http://dx.doi.org/10.1056/NEJMoa043596

[31]   Szefler, S.J., Mitchell, H., Sorkness, C.A., Gergen, P.J., O’Connor, G.T., Morgan, W.J., et al. (2008) Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: A randomised controlled trial. Lancet, 372, 1065-1072. http://dx.doi.org/10.1016/S0140-6736(08)61448-8

[32]   Petsky, H.L., Cates, C.J., Li, A., Kynaston, J.A., Turner, C. and Chang, A.B. (2008) Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults. Cochrane Database of Systematic Reviews, CD006340.

[33]   Pike, K., Selby, A., Price, S., Warner, J., Connett, G., Legg, J., Lucas, J.S., Peters, S., Buckley, H., Magier, K., Foote, K., Drew, K., Morris, R., Lancaster, N. and Roberts, G. (2012) Exhaled nitric oxide monitoring does not reduce exacerbation frequency or inhaled corticosteroid dose in paediatric asthma: A randomised controlled trial. Clinical Respiratory Journal.

[34]   Barben, J., Kuehni, C.E., Strippoli, M.P., Schiller, B., Hammer, J., Trachsel, D., et al. (2011) Mannitol dry powder challenge in comparison with exercise testing in children. Pediatric Pulmonology, 46, 842-848. http://dx.doi.org/10.1002/ppul.21453

[35]   Anderson W.J. and Lipworth B.J. (2012) Relationship of mannitol challenge to methacholine challenge and inflammatory markers in persistent asthmatics receiving inhaled corticosteroids. Lung, 190, 513-521. http://dx.doi.org/10.1007/s00408-012-9396-6

[36]   Sverrild, A., Malinovschi, A., Porsbjerg, C., Backer, V. and Alving, K. (2013) Predicting airway hyperreactivity to mannitol using exhaled nitric oxide in an unselected sample of adolescents and young adults. Respiratory Medicine, 107, 150-152. http://dx.doi.org/10.1016/j.rmed.2012.09.004

[37]   Andregnette-Roscigno, V., Fernández-Nieto, M., Arochena, L., García Del Potro, M., Aguado, E. and Sastre, J. (2012) Methacholine is more sensitive than mannitol for evaluation of bronchial hyper-responsiveness in youth athletes with exercise-induced bronchoconstriction. Pediatric Allergy and Immunology, 23, 501-503. http://dx.doi.org/10.1111/j.1399-3038.2012.01293.x

[38]   Kersten, E.T.G., Driessen, J.M.M., Duiverman, E.J. and Thio, B.J. (2011) The effect of stepping down combination therapy on airway hyperresponsiveness to mannitol. Respiratory Medicine, 105, 691-697. http://dx.doi.org/10.1016/j.rmed.2010.11.008

[39]   Lipworth, B.J., Short, P.M., Williamson, P.A., Clearie, K.L., Fardon, T.C. and Jackson, C.M. (2012) A randomized primary care trial of steroid titration against mannitol in persistent asthma: STAMINA trial. Chest, 141, 607-615. http://dx.doi.org/10.1378/chest.11-1748

[40]   Piacentini, G.L., Peroni, D.G., Bodini, A., Bonafiglia, E., Rigotti, E., Baraldi, E., Liu, A.H. and Boner, A.L. (2009) Childhood Asthma Control Test and airway inflammation evaluation in asthmatic children. Allergy, 64, 1753-1757. http://dx.doi.org/10.1111/j.1398-9995.2009.02068.x

[41]   ATS/ERS (2005) ATS/ERS Recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. American Journal of Respiratory and Critical Care Medicine, 171, 912-930. http://dx.doi.org/10.1164/rccm.200406-710ST

[42]   American Thoracic Society. (1995) Standardization of spirometry, 1994 update. American Journal of Respiratory and Critical Care Medicine, 152, 1107-1136. http://dx.doi.org/10.1164/ajrccm.152.3. 7663792

[43]   Zapletal, A., Samanek, M. and Paul, T. (1987) Lung function in children and adolescents. Methods and reference values. Progress in Respiration Research, 22, 83-112.

[44]   Barben, J., Roberts, M., Chew, N., Carlin, J.B. and Robertson, C.F. (2003) Repeatability of bronchial responsiveness to mannitol dry powder in children with asthma. Pediatric Pulmonology, 36, 490-494. http://dx.doi.org/10.1002/ppul.10378

[45]   Brannan, J., Anderson, S., Perry, C., Freed-Martens, R., Lassig, A., Charlton, B., et al. (2005) The safety and efficacy of inhaled dry powder mannitol as a bronchial provocation test for airway hyperresponsiveness: A phase 3 comparison study with hypertonic (4.5%) saline. Respiratory Research, 6, 144. http://dx.doi.org/10.1186/1465-9921-6-144

[46]   Juniper, E.F., Guyatt, G.H., Feeny, D.H., Ferrie, P.J., Griffith, L.E. and Townsend, M. (1996) Measuring quality of life in children with asthma. Quality of Life Research, 5, 35-46. http://dx.doi.org/10.1007/ BF00435967

[47]   National Asthma Education and Prevention Program (2007) Expert Panel Report 3 (EPR-3): Guidelines for the diagnosis and management of Asthma summary report 2007. The Journal of Allergy and Clinical Immunology, 120, S94-S138. http://dx.doi.org/10.1016/j.jaci.2007.09.029

[48]   National Institutes of Health National Heart, Lung and Blood Institite NIH NHLBI (1997) National Asthma Education and Prevention Program (NAEPP) Expert Panel Report II. Guidelines for the diagnosis and management of asthma. NIH Publication, 97-4951 A: 29.

[49]   Paull, K., Covar, R., Jain, N., Gelfand, E.W. and Spahn, J.D. (2005) Do NHLBI lung function criteria apply to children? A cross-sectional evaluation of childhood asthma at National Jewish Medical and Research Center, 1999-2002. Pediatric Pulmonology, 39, 311-317. http://dx.doi.org/10.1002/ ppul.20161

[50]   Mitra, A.D., Ogston, S., Crighton, A. and Mukhopadhyay, S. (2002) Lung function and asthma symptoms in children: Relationships and response to treatment. Acta Paediatrica, 91, 789-792. http://dx.doi.org/10.1111/j.1651-2227.2002.tb03328.x

[51]   Verini, M., Rossi, N., Dalfino, T., Verrotti, A., Di Gioacchino, M. and Chiarelli, F. (2001) Lack of Correlation between clinical patterns of asthma and airway obstruction. Allergy and Asthma Proceedings, 22, 297-302.

[52]   Rasmussen, F., Taylor, D.R., Flannery, E.M., Cowan, J.O., Greene, J.M., Herbison, G.P. et al. (2002) Risk factors for airway remodeling in asthma manifested by a low postbronchodilator FEV1/Vital capacity ratio: A longitudinal population study from childhood to adulthood. American Journal of Respiratory and Critical Care Medicine, 165, 1480-1488. http://dx.doi.org/10.1164/rccm.2108009

[53]   Sears, M.R., Greene, J.M., Willan, A.R., Wiecek, E.M., Taylor, D.R., Flannery, E.M. et al. (2003) A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. New England Journal of Medicine, 349, 1414-1422. http://dx.doi.org/10.1056/NEJMoa022363

[54]   Grol, M.H., Gerritsen, J., Vonk, J.M., Schouten, J.P., Koeter, G.H., Rijcken, B. And Postma, D.S. (1999) Risk factors for growth and decline of lung function in asthmatic individuals up to age 42 years. A 30-year follow-up study. American Journal of Respiratory and Critical Care Medicine, 160, 1830-1837. http://dx.doi.org/10.1164/ajrccm.160.6.9812100

[55]   Payne, D.N., Adcock, I.M., Wilson, N.M., Oates, T., Scallan, M. and Bush, A. (2001) Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. American Journal of Respiratory and Critical Care Medicine, 164, 1376-1381. http://dx.doi.org/10.1164/ajrccm.164.8.2101145

[56]   Berkman, N., Avital, A., Breuer, R., Bardach, E., Springer, C. and Godfrey, S. (2005) Exhaled nitric oxide in the diagnosis of asthma: Comparison with bronchial provocation tests. Thorax, 60, 383-388. http://dx.doi.org/10.1136/thx.2004.031104

[57]   de Jongste, J.C., Carraro, S., Hop, W.C., The CHARISM Study Group and Baraldi, E. (2009) Daily telemonitoring of exhaled nitric oxide and symptoms in the treatment of childhood asthma. American Journal of Respiratory and Critical Care Medicine, 179, 93-97. http://dx.doi.org/10.1164/rccm. 200807-1010OC

[58]   Roberts, G., Mylonopoulou, M., Hurley, C. and Lack, G. (2005) Impairment in quality of life is directly related to the level of allergen exposure and allergic airway inflammation. Clinical & Experimental Allergy, 35, 1295-1300. http://dx.doi.org/10.1111/j.1365-2222.2005.02333.x

[59]   Khalili, B., Boggs, P.B., Shi, R. and Bahna, S.L. (2008) Discrepancy between clinical asthma control assessment tools and fractional exhaled nitric oxide. Annals of Allergy, Asthma & Immunology, 101, 124-129. http://dx.doi.org/10.1016/S1081-1206(10)60199-8

[60]   Stelmach, I., Podlecka, D., Majak, P., Jerzynska, J., Stelmach, R., Janas, A., Krakowiak, J. and Stelmach, W. (2011) Validity of the pediatric asthma quality of life questionnaire in polish children. Pediatric Allergy and Immunology, 22, 660-666. http://dx.doi.org/10.1111/j.1399-3038.2011.01162.x

[61]   Decimo, F., Capristo, C., Amelio, R., Maiello, N., Capristo, A.F. and Miraglia Del Giudice, M. (2011) Evaluation of bronchial hyperreactivity with mannitol dry powder challenge test in a paediatric population with intermittent allergic asthma or allergic rhinitis. International Journal of Immunopathology and Pharmacology, 24, 1069-1074.